, Kaltschmidt, B
Firstly, this study was conducted using a relatively small number of participants
LC 50 for K1 cells was ~ 0.4 M, whereas RSL3 treatment did not significantly affect TPC-1 cell viability, suggesting RSL3 selectively inhibits RAS/BRAF -mutant cell lines, such as K1, MDA-T32, and MDA-T68 (Fig
Biotin NHS Based on 23 publication(s) in Google Scholar Biotin NHS is an amino reactive biotin reagent used in the preparation of biotinylated surfaces or polypeptides
In this trial, researchers administered acute single doses (250, 500, 1,000, 2000 mg/day) and chronic doses of oral UA for 4 weeks (250, 500, 1,000 mg/day, 7 days/week) to healthy, sedentary elderly individuals, assessing both safety and bioavailability